Rink Amide Resin
(Synonyms: 三联苯二羧酸) 目录号 : GA11149肽酰胺的 SPS
Cas No.:13653-84-4
Sample solution is provided at 25 µL, 10mM.
Rink resin is originally developed for SPS of peptide amides. Now the scope of its application is extended from carboxylic amides to the immobilization of amines, substituted amides. Libaries of primary amines have been synthesized by the treatment of Rink amine resin with aldehyde to form aldimines, which are subsequently reacted with Grignard reagents or lithium reagents to yield amines that are not commercially available. These amines are released from resin by treatmnet with TFA-water-DCM (5:5:90) for 5 h at room temperature. N-Substituted amides are obtained by reducing the above-mentioned aldimines with Na(CN)BH3 to the corresponding amines, followed by acylation with acid chlorides or symmetrical anhydrides. The produts are cleaved with TFA-water-DCM (5:1:94) for 20 min at room temperature. Direct functionalization of Rink amide resin with nucleophiles has also been reported. The Fmoc protecting group can be readly removed with 20% piperidine in DMF prior to the above manipulation.
Rink amide resin: 4-(2',4'-Dimethoxyphenyl-Fmoc-aminomethyl-phenoxy-acetamido- norleucylaminomethyl resin; Substitution: 0.4 - 0.8 mmole/g resin; Bead size 100- 200 mesh (polystyrene- 1% DVB)
Structure: Application: Li et al reported a simple, clean, high yielding and linker-free method for the synthesis of disubstituted guanidines by using Rink amide resin as an amine component [1]. Decomposition of the resin linkers during TFA cleavage of the peptides in the Fmoc strategy leads to alkylation of sensitive amino acids. The C-terminal amide alkylation, reported for the first time, is shown to be a major problem in peptide amides synthesized on the Rink amide resin. This side reaction occurs as a result of the Rink amide linker decomposition under TFA treatment of the peptide resin. The use of 1,3-dimethoxybenzene in a cleavage cocktail prevents almost quantitatively formation of C-terminal N-alkylated peptide amides. Oxidized by-product in the tested Cys- and Met-containing peptides were not observed, even if thiols were not used in the cleavage mixture[2].
Reference:
[1] Min Li, Lawrence J. Wilson and David E. Portlock. A simple solid-phase synthesis of disubstituted guanidines using Rink amide resin as an amine component. Tetrahedron Letters 42 (2001) 2273–2275
[2] Stathopoulos P, Papas S, Tsikaris V. C-terminal N-alkylated peptide amides resulting from the linker decomposition of the Rink amide resin: a new cleavage mixture prevents their formation. J Pept Sci. 2006;12(3):227-32.
Cas No. | 13653-84-4 | SDF | |
别名 | 三联苯二羧酸 | ||
化学名 | [1,1':4',1''-terphenyl]-4,4''-dicarboxylic acid | ||
Canonical SMILES | O=C(O)C1=CC=C(C2=CC=C(C3=CC=C(C(O)=O)C=C3)C=C2)C=C1 | ||
分子式 | C20H14O4 | 分子量 | 318.32 |
溶解度 | 储存条件 | ||
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.1415 mL | 15.7075 mL | 31.4149 mL |
5 mM | 0.6283 mL | 3.1415 mL | 6.283 mL |
10 mM | 0.3141 mL | 1.5707 mL | 3.1415 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet